期刊文献+

非那雄胺预防前列腺增生急性尿潴留的临床观察 被引量:7

Clinical effects of finasteride on preventing prostate hyperplasia with acute urinary retention
原文传递
导出
摘要 目的观察非那雄胺预防前列腺增生急性尿潴留的疗效。方法626例良性前列腺增生(BPH)患者分为治疗组316例与对照组310例,随访3年,对急性尿潴留的发生率和前列腺体积的变化进行对比。结果治疗组急性尿潴留3例(1.0%)、对照组13例(4.2%),两组比较差异有统计学意义(x2=5.37,P〈0.05),治疗组前列腺的体积较服药前平均缩小23.6%,对照组观察期间前列腺的体积平均增大12.3%。结论非那雄胺通过缩小前列腺的体积降低BPH急性尿潴留发生的风险。 Objective To study the effect of finasteride on preventing prostate hyperplasia with acute urinary retention. Methods Totally 626 patients with benign prostatic hyperplasia (BPH) were randomly divided into treatment group (316 cases) and control group (310 cases), followed up for 3 years. The incidence of acute urinary retention and prostate volume changes were analyzed. Results There were 3 cases of acute urinary retention in treatment group (1.0 %), 9 cases in control group (2.9 ~) (%2 = 5.37, P^0.05). In treatment group, the average prostate volume was reduced about 23.6% compared with before taking the medicine, on the contrary, prostate volume was averagely increased 12.3% in control group. Conclusions Finasteride can reduce the risk of acute urinary retention by narrowing the prostate volume in patients of benign prostatic hyperplasia.
作者 刘渊
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第12期1085-1086,共2页 Chinese Journal of Geriatrics
关键词 前列腺增生 尿潴留 Prostatic hyperplasia Urinary retention
  • 相关文献

参考文献1

共引文献118

同被引文献69

  • 1王东文,双卫兵,高俊平,张旭,高宏飞,吴博威,叶章群.非胰岛素依赖型糖尿病大鼠膀胱兴奋性自律性以及舒缩功能的改变[J].中华实验外科杂志,2004,21(12):1533-1536. 被引量:26
  • 2崔喆,尹鉴淳,张和平,李黎明,强万明.尿动力学检查在糖尿病患者膀胱功能评定中的意义[J].中华泌尿外科杂志,2005,26(4):250-252. 被引量:15
  • 3牛海涛,张勤,赵伟,张宗亮,张一兵,邱志磊,杨惠祥,孙光.良性前列腺增生并发急性尿潴留的危险因素预测以及临床意义[J].中华泌尿外科杂志,2007,28(6):407-410. 被引量:17
  • 4Michel MC,Mehlburger L,Schumacher H,et al.Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia[J].J Urol,2000;163(6):1725-9.
  • 5Woderich R,Fowler CJ.Management of lower urinary tract symptoms in men with progressive neurological disease[J].Curr Opin Urol,2006;16(1):30-6.
  • 6Roosen A,Gratzke C,Herrlemann A,et al.Etiology and pathophysiology of benign prostate hyperplasia[J].Urologe A,2013;52(2):186-92.
  • 7Siracusano S,d'Aloia G,Lentini MG,et al.Diabetic cystopathy[J].Diabet Nutr Metab,2002;15(1):41-4.
  • 8Mara A. Monoski,Ricardo R. Gonzalez,Jaspreet S. Sandhu,Balaji Reddy,Alexis E. Te.Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention[J]. Urology . 2006 (2)
  • 9C Mamoulakis,I Efthimiou,S Kazoulis,I Christoulakis,F Sofras.The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World Journal of Urology . 2011
  • 10Oelke M,Bachmann A,Descazeaud AA,et al. EAU guide- lines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign pro- static obstruction[J]. Eur Uro1,2013,64-( 1 ) : 118-140.

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部